News

Deal Announcements

Adaptive TCR Receives New VC Funding

Tuesday, March 30, 2010 5:58:00 AM PDT | VentureDeal Staff

Seattle, Washington  --  Biotechnology company Adaptive TCR has garnered $4.5 million in a new round of venture capital investment.

Adaptive has developed a proprietary profiling platform for T-cell receptors via high throughput sequencing.

Investors in the round were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.